As a leading enterprise in China’s medical equipment industry, a medical equipment manufacturer’s main business is medical equipment and its overall technical solutions. Its products have been exported to nearly 60 countries and regions in Asia, Europe, South America, etc., and its international market share is increasing rapidly year by year.

Project challenge

Due to the impact of the novel coronavirus epidemic and the increasing demand for drugs from China’s aging population, the construction investment of new pharmaceutical plants in China has been expanding, and the equipment manufacturers have also developed rapidly. In addition to special drug equipment, they have been involved in EPC projects and drug research and development of the entire pharmaceutical plant. However, in recent years, it has also faced the pressure of market competition, and has faced great challenges in improving quality and capacity efficiency, especially in reducing costs.

In order to continuously improve customer responsiveness and product competitiveness, the device is always looking for a provider that can provide innovative I/O technology to meet the multiple challenges in sterile device applications.

The automated aseptic process production line itself is distributed in a large and scattered area, spanning multiple isolation rooms, and GMP (” Good Practice for the Quality Management of Pharmaceutical Production “, hereinafter referred to as GMP) requires that the field pipeline is simple and easy to clean.
Given the importance and quality requirements of aseptic equipment, I/O modules require faster and more accurate response capabilities that allow reliable diagnosis and intelligent maintenance services for equipment and production conditions remotely.
The space of the field control cabinet is limited, and the I/O module needs to minimize the space occupation.
I/O modules need to be simpler and faster to deploy, so that they can be delivered quickly to downstream pharmaceutical customers and reduce overall costs, improving the overall competitiveness of the equipment.
The rapidly developing remote I/O technology, as the “bridge” connecting signal and data in modern pharmaceutical equipment, is often used in the automated control system of pharmaceutical equipment, which is a key part of creating automated and digital pharmaceutical equipment, so as to realize the data collection, transmission and control of the drug production process and equipment status, and ultimately help improve production efficiency and drug quality. Reduce compliance costs for your business.

IC687RCM711

The UR20 remote I/O technology provided by Weidmuller, including fieldbus couplers and a variety of DI/DO digital input and output modules, is responsible for the key tasks of collecting data of various sterile pharmaceutical production equipment and process and output execution signals, mainly DI\DO and AI\AO modules. Realize the signal processing and transmission of various sensors, positioning devices and motion devices on site.

The use of Weidmuller distributed UR20 remote I/O is suitable for distributed signal processing and can better meet the GMP compliance requirements of sterile preparation lines.
The UR20 high-speed system bus enables 256 DI/DO status updates within 20μs, providing a very fast response time for aseptic device applications, fast addressing capability and accurate mapping of system processes, and a powerful power reserve function that can reserve up to 1024 I/O points for expansion. And the LED status indicator on each I/O module and channel can help with reliable on-site diagnostic services.
In the control cabinet of aseptic equipment, the UR20 module adopts an ultra-thin design and reduces the use of feed modules to reduce space consumption.
IN terms of installation, the UR20 adopts the “PUSH IN” in-line wiring technology, and customers only need to insert the wire with the tubular end into the bottom of the wire frame to complete the wiring, which greatly saves deployment time and improves delivery capacity.

Customer benefits

The benefits of using Weidmuller’s UR20 remote I/O technology include:

Easy pipeline cleaning, easy to meet production management quality standards, thereby reducing pharmaceutical plant compliance costs;
Optimized equipment technology and improved production quality; By monitoring the running state of the pharmaceutical equipment components, the availability of the equipment is guaranteed and the reliability of the pharmaceutical process is improved.
Save more space in the cabinet, save up to 50% time compared to the traditional wiring method;
Reduced start-up time for equipment and systems helps speed up production times for pharmaceutical projects
Final effect

Medicines are vital for public health. As the source of drug production, pharmaceutical equipment directly determines the production quality, capacity, cost and efficiency of drugs. With the development of automation and information technology, the R&D and application innovation of China’s pharmaceutical equipment has ushered in a new round of revolutionary driving force.

With the support of the UR20 remote I/O technology provided by Weidmuller, the equipment manufacturer has created a more reliable, efficient, simple and intelligent asepia-level equipment, which has laid a good foundation for consolidating its leading position and opening up the international high-end market.